Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Envivo Pharmaceuticals, Inc.filedCriticalEnvivo Pharmaceuticals, Inc.
Publication of HK1155152ApublicationCriticalpatent/HK1155152A/en
Di-substituted phenyl compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. The disclosure also relates to methods for treating neurological, neurodegenerative and psychiatric disorders including but not limited to those comprising cognitive deficits or schizophrenic symptoms.
HK11108948.3A2008-06-252009-06-25Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
HK1155152A
(en)